Skip to content

Clinical trials

Phase 3 Gastrointestinal Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Diseases Phase: Phase 3 Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20091
20111
20121
20161
20171
20201
20212
20222
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Celgene2
Pfizer2
Abbott Nutrition1
Ellodi Pharmaceuticals, LP1
Forest Laboratories1
Furiex Pharmaceuticals, Inc1
InDex Pharmaceuticals1
Seres Therapeutics, Inc.1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Diseases14
Digestive System Diseases7
Intestinal Diseases6
Colonic Diseases5
Colorectal Neoplasms3
Digestive System Neoplasms3
Eosinophilia3
Eosinophilic Esophagitis3
Esophageal Diseases3
Esophagitis3

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.